Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Chicago, IL
NPI: 1558327486Primary Practice Location
NORTHWESTERN MEMORIAL HOSPITAL
250 E Superior St, Chicago, IL
Primary Employer
Northwestern Medical Group
nm.org
HQ Phone
Get M.D. Daniela's Phone Numberphone_androidMobile
Get M.D. Daniela's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIN State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 51 | 161 |
| 2 | 96413Infusion of chemotherapy into a vein up to 1 hour | 32 | 76 |
| 3 | 96375Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | 16 | 66 |
| 4 | J1100Injection, dexamethasone sodium phosphate, 1 mg | 15 | 300 |
| 5 | 96417Infusion of different chemotherapy drug or substance into a vein up to 1 hour | 14 | 31 |
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022.
Authors: Premal Thaker, John Schorge, Mihaela Cristea, Gottfried Konecny, Lainie Martin, Angela Jain, Lisa Barroilhet, Jamie Bakkum-Gamez, Gary Leiserowitz, Lee-May Chen, Michael Mchale, Heidi Gray, Ronald Alvarez, David Gershenson, Amer Karam, Rachel Grisham, Kian Behbakht, Emese Zsiros, Daphne Stewart
Publication Date: 2022-09
Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86).
Authors: Mihaela Cristea, Angela Jain, Gini Fleming
Publication Date: 2019-08-11
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, BIOLOGICAL: Nivolumab, PROCEDURE: Biospecimen Collection, PROCEDURE: Computed Tomography, DRUG: Cabozantinib S-malate, PROCEDURE: Biopsy Procedure
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: PROCEDURE: Bone Marrow Biopsy, PROCEDURE: Biospecimen Collection, DRUG: Olaparib, PROCEDURE: Computed Tomography, BIOLOGICAL: Durvalumab, PROCEDURE: Multigated Acquisition Scan, PROCEDURE: Echocardiography, PROCEDURE: Bone Marrow Aspirate, DRUG: Capivasertib, DRUG: Cediranib Maleate
Lead Sponsor: Northwestern University
Collaborators: Merck Sharp & Dohme LLC, National Cancer Institute (NCI), Astex Pharmaceuticals, Inc.
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, BIOLOGICAL: Pembrolizumab, DRUG: Guadecitabine
